Zobrazeno 1 - 10
of 12
pro vyhledávání: '"R.M. Carretero"'
Autor:
M.C. Castro, Maria Angeles Aguirre, Yolanda Jimenez-Gomez, Constantino Martínez, Patricia Ruiz-Limon, Pilar Font, R.M. Carretero, Nuria Barbarroja, Alejandro Escudero, C. Perez-Sanchez, C. Lopez-Pedrera, Eduardo Collantes-Estevez, Rocío González-Conejero
Publikováno v:
Annals of the Rheumatic Diseases. 73:133.3-134
Background The advent of anti-TNFα drugs has considerably improved medical management in Rheumatoid Arthritis (RA) patients, although it has been reported to be ineffective in a fraction of them. MicroRNAs (miRNAs) are small, non-coding RNAs that ac
Autor:
P. Ruiz-Limon, Juan R. Muñoz-Castañeda, Alejandro Escudero, Nuria Barbarroja, C. Lopez-Pedrera, Carmen Herencia, Eduardo Collantes, R.M. Carretero, C. Perez-Sanchez, Yolanda Jimenez-Gomez, T. Cerdo-Raez
Publikováno v:
Annals of the Rheumatic Diseases. 73:442.2-442
Background Spondyloarthropathies are a group of chronic inflammatory diseases characterized by progressive new bone formation leading to ankylosis and functional disability. TNF antagonists are effective and safe long-term treatments in patients with
Autor:
C. Lopez-Pedrera, Rocío González-Conejero, R.M. Carretero, Nuria Barbarroja, Patricia Ruiz-Limon, Eduardo Collantes, M. J. Cuadrado, Constantino Martínez, C. Perez-Sanchez, Maria Angeles Aguirre
Publikováno v:
Annals of the Rheumatic Diseases. 73:342.2-342
Background miRNAs are key players in pathophysiological processes, but no previous studies have investigated their asscociation with the cardiovascular and atherothrombotic risks observed in primary antiphospholipid syndrome (APS) and systemic lupus
Autor:
Patricia Ruiz-Limon, Nuria Barbarroja, Rocío González-Conejero, C. Lopez-Pedrera, Antonio Rodríguez-Ariza, Maria Angeles Aguirre, Raúl Teruel, M. J. Cuadrado, Eduardo Collantes, C. Martíez, C. Perez-Sanchez, R.M. Carretero
Publikováno v:
Annals of the Rheumatic Diseases. 72:A822.2-A822
Background miRNAs are key players in a wide range of molecular and pathophysiological processes. Recently, several studies have examined their involvement in the pathogenesis of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS).
Autor:
Patricia Ruiz-Limon, R.M. Carretero, Antonio Rodríguez-Ariza, C. Lopez-Pedrera, M. J. Cuadrado, FG Martinez, Maria Angeles Aguirre, C. Perez-Sanchez, I. Gomez-Gracia, Nuria Barbarroja, Eduardo Collantes-Estevez, Pilar Font
Publikováno v:
Annals of the Rheumatic Diseases. 71:485.3-485
Background Oxidative stress and chronic inflammation impair white blood cells and endothelial cells activities in rheumatoid arthritis (RA) patients, which eventually result in the early atherogenesis and the cardiovascular disease (CVD) displayed by
Autor:
C. Perez-Sanchez, Eduardo Collantes, Patricia Ruiz-Limon, Nuria Barbarroja, R.M. Carretero, Munther A. Khamashta, Maria Angeles Aguirre, C. Lopez-Pedrera, M. J. Cuadrado, Sebastiano Messineo, Antonio Rodríguez-Ariza
Publikováno v:
Annals of the Rheumatic Diseases. 72:A79.2-A79
Background Systemic lupus erythematosus (SLE) is characterized by immune-mediated inflammation in multiple organ systems. SLE, primary Antiphospholipid syndrome (APS) and secondary APS (SAPS) share several clinical features, including atherosclerosis
Autor:
Nuria Barbarroja, M. J. Cuadrado, C. Lopez-Pedrera, Antonio Rodríguez-Ariza, Patricia Ruiz-Limon, Eduardo Collantes-Estevez, Maria Angeles Aguirre, M L Bertolaccini, C. Perez-Sanchez, R.M. Carretero, Munther A. Khamashta
Publikováno v:
Annals of the Rheumatic Diseases. 71:526.2-526
Background Atherosclerosis (AT) and cardiovascular disease (CVD) are enhanced in autoimmune diseases, such as antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Characterization of the molecular and cellular basis of signalling a
Autor:
Eduardo Collantes-Estevez, N. Barbarroja, P. Ruiz-Limon, M. Khamashta, M.A. Aguirre, José M. Villalba, R.M. Carretero, Antonio Rodríguez-Ariza, C. Perez-Sanchez, M.J. Cuadrado, C. Lopez-Pedrera, Francisco Velasco
Publikováno v:
Atherosclerosis Supplements. 12:89
Autor:
N. Barbarroja, C. Lopez-Pedrera, M. Khamashta, José M. Villalba, Eduardo Collantes-Estevez, M.A. Aguirre, Antonio Rodríguez-Ariza, Francisco Velasco, C. Perez-Sanchez, M.J. Cuadrado, P. Ruiz-Limon, R.M. Carretero
Publikováno v:
Atherosclerosis Supplements. 12:67
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.